I listened to the webinars again on the front page of MMTCs site and I think John Ricardi speaks directly to that point. It sounds like they still have some work to do before they hit hard with the marketing of the MIT-1000. I think the most significant goal right now is getting the other two bacteria reviewed and certified by AOAC (my opinion). Not saying that they'll wait to do a full scale launch of the product until then, yet that would make sense to me. I believe we are in process of getting those two additional certs as we speak ( per webinars I listened to this morning).
Possible news near term.
1. Partnership agreement (per webinar) 2. Sales as/if they occur (per webinar) 3. Two additional bacteria certified with AOAC (per webinar) 4. Updated sales/marketing initiative 5. Additional funding agreements
This is my opinion. Please do your own DD before you decide to buy or sell.
Market Data 
Markets 
AI
